Silvia Auxilia

Dr. Silvia Auxilia


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2020 in Veterinary Dermatology
Verified
Journal Article
Open access
PDF file
CDCatharina M.M. van Damme
Catharina M.M. van Damme
EBEls Broens
Els Broens
SASilvia Auxilia
Silvia Auxilia
YSYvette M. Schlotter
Yvette M. Schlotter
Background: In the Netherlands there is a lack of data regarding resistance of Staphylococcus pseudintermedius to the systemic antimicrobial drugs used for the treatment of superficial pyoderma.Objectives: To assess antimicrobial resistance, with emphasis on resistance to clindamycin and meticillin, in clinical isolates of S. pseudintermedius isolated from dogs with superficial pyoderma. Results were compared between dogs with and without a history of systemic antimicrobial therapy during the previous year.Animals: A retrospective study of 237 referral cases presented to an academic teaching hospital between 2014 and 2019, with the clinical and microbiological diagnosis of superficial pyoderma.Methods and materials: All clinical isolates were identified primarily by MALDI‐TOF mass spectrometry. Antimicrobial susceptibility was tested either by an agar diffusion method (2014–2016) or by broth microdilution. Antimicrobial history in the preceding year was obtained from medical records.Results: Meticillin‐resistant S. pseudintermedius (MRSP) was isolated from 8% of superficial pyoderma cases. Within the meticillin‐susceptible S. pseudintermedius (MSSP) population, clindamycin resistance was significantly more common in isolates derived from dogs with histories of antimicrobial treatment (37.7%) compared to dogs with no histories of exposure (21.7%; P = 0.03).Conclusions: Given the high prevalence of clindamycin resistance in MSSP isolated from dogs with prior antimicrobial exposure, it is recommended that bacterial culture and susceptibility testing be pursued before prescribing systemic antimicrobials. Clindamycin should be regarded as the preferred treatment option if susceptibility is confirmed, due to its narrow spectrum and reduced selective pressure for MRSP.

21 November 2024 in Veterinary Dermatology
Verified
Journal Article
Closed access
CLCarlos Fernández Lozano
Carlos Fernández Lozano
AMAna Mas
Ana Mas
SASilvia Auxilia
Silvia Auxilia
MWMarie Welters
Marie Welters
AOAlla Olivrī
Alla Olivrī
Thierry OlivryThierry Olivry
Thierry Olivry

27 August 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
MWMarie Welters
Marie Welters
AMAna Mas
Ana Mas
SASilvia Auxilia
Silvia Auxilia
Thierry OlivryThierry Olivry
Thierry Olivry
Extracts used for allergen sensitization testing in humans are heterogeneous in composition and may contain low levels of important allergens. In contrast, there is scant information on the variability of veterinary allergen extracts. We selected two batches of extracts of Dermatophagoides farinae house dust mites from each of three different manufacturers. We observed a 3.4-fold difference in total protein content between the two extracts with the lowest and highest amounts of allergens. After electrophoresis, the band migration patterns were found to be similar between the two batches of extracts from two manufacturers and dissimilar in the third; the migration profiles were heterogeneous between manufacturers. The six extracts did not contain the same concentrations of Der f 1 and Der f 2, with fold changes between the highest and lowest concentrations measured to be 14.3× for Der f 1 and 8.0× for Der f 2. This allergen composition heterogeneity resulted in differences in ELISA seropositivity when allergic dogs had low serum concentrations of IgE against Der f 1 and Der f 2. Our findings demonstrate that, like in human allergology, allergen extracts for veterinary use are also heterogeneous in their protein content and allergen composition. This heterogeneity can impact results when determining allergen sensitizations using crude extracts.

9 October 2025 in Veterinary Record Case Reports
Verified
Journal Article
Open access
TDThomas Dijkxhoorn
Thomas Dijkxhoorn
SASilvia Auxilia
Silvia Auxilia
MWMarie Welters
Marie Welters
NVNathalie De Vries
Nathalie De Vries
MPMargreet Ploeg
Margreet Ploeg
This report describes a case of severe, sudden‐onset, widespread vasculitis affecting a dog concurrently infected by E hrlichia canis and Babesia canis . Following diagnostic investigations, the dog was suspected of an immune‐mediated vasculitis, possibly triggered by E. canis, B. canis or their combination. The lesions completely resolved after a multimodal treatment protocol including prednisolone, ciclosporin, pentoxifylline, doxycycline and imidocarb dipropionate.